Program Committee

Program Committee Members

Aanand D. Naik, MD, 2023 AGS Annual Scientific Meeting Chair
Nicole J. Brandt, PharmD, MBA, BCGP, BCPP, FASCP  
Anna Chang, MD
Lenise Cummings-Vaughan, MD
Kathryn M. Daniel, PhD, RN, ANP-BC, GNP-BC, AGSF
Donna Fick, PhD, GCNS-BC, AGS President-elect
Ellen Flaherty, PhD, APRN, BC
G. Michael Harper, MD, AGSF, AGS President
Amy Kelley, MD
Annie Medina-Walpole, MD, PEEC Chair
James T. Pacala, MD, MS
Joseph Shega, MD
Liron Sinvani, MD
Camille Vaughan, MD

Disclosure of relationships with ineligible companies

As an ACCME accredited provider of Continuing Medical Education, the American Geriatrics Society must ensure balance, independence, objectivity and scientific rigor in all of our educational activities. We have implemented a process wherein everyone who is in a position to control the content of an education activity has disclosed to us all financial relationships with any ineligible company within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  AGS then reviews the disclosure information to determine which financial relationships are relevant and mitigates relevant financial relationships with ineligible companies to prevent commercial bias in the content.  

Members of the 2023 Annual Meeting Program Committee did not have any current relevant financial relationships with ineligible companies, so no mitigation was required.